CDEK
← All drugs Report issue

geptanolimab

mAbexperimental

Clinical trial activity

8 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
5
Phase 3
0
Phase 4
0

Earliest trial started Oct 19, 2017 (NCT03374007)

Timeline

2010s

  1. Jan 1, 2017

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05873244Phase 2Aug 21, 2023Chinese University of Hong Kong
NCT03976856Phase 1Jun 30, 2019Genor BioPharma Co., Ltd., Hutchison MediPharma, Jiao Tong University
NCT03977090Phase 1Apr 4, 2019Genor BioPharma Co., Ltd., Hutchison MediPharma
NCT03808857Phase 2Feb 28, 2019Genor BioPharma Co., Ltd.
NCT03639181Phase 2Jun 15, 2018Chinese Academy of Medical Sciences, Genor BioPharma Co., Ltd.
NCT03623581Phase 2Mar 15, 2018Chinese Academy of Medical Sciences, Genor BioPharma Co., Ltd.
NCT03502629Phase 2Mar 15, 2018Chinese Academy of Medical Sciences, Genor BioPharma Co., Ltd.
NCT03374007Phase 1Oct 19, 2017Chinese Academy of Medical Sciences, Genor BioPharma Co., Ltd.
Showing 8 of 8 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Genor BioPharma Co., Ltd.For profit7722017
Chinese Academy of Medical SciencesAcademic/Hospital4022017
Hutchison MediPharmaFor profit2012019
Chinese University of Hong KongAcademic/Hospital1112023
Jiao Tong UniversityAcademic/Hospital1012019
5 organizations
Page 1 / 1